These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 19070992

  • 1. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
    De Logu A, Palchykovska LH, Kostina VH, Sanna A, Meleddu R, Chisu L, Alexeeva IV, Shved AD.
    Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
    [Abstract] [Full Text] [Related]

  • 2. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
    Sood R, Rao M, Singhal S, Rattan A.
    Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988
    [Abstract] [Full Text] [Related]

  • 3. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
    Foroumadi A, Soltani F.
    Boll Chim Farm; 2003 Jun; 142(6):248-50. PubMed ID: 14606264
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives.
    Santos JL, Yamasaki PR, Chin CM, Takashi CH, Pavan FR, Leite CQ.
    Bioorg Med Chem; 2009 Jun 01; 17(11):3795-9. PubMed ID: 19427791
    [Abstract] [Full Text] [Related]

  • 5. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A, Soltani F, Moshafi MH.
    Boll Chim Farm; 2002 Jun 01; 141(5):394-6. PubMed ID: 12481384
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
    Abate G, Koivula T, Hoffner SE.
    Int J Tuberc Lung Dis; 2002 Oct 01; 6(10):933-5. PubMed ID: 12365582
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S, Sechi LA, Molicotti P, Cannas S, Bua A, Deriu A, Carta A, Paglietti G.
    Int J Antimicrob Agents; 2005 Feb 01; 25(2):179-81. PubMed ID: 15664491
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H, Haraguchi Y, Itotani M, Kuroda H, Hashizume H, Tomishige T, Kawasaki M, Matsumoto M, Komatsu M, Tsubouchi H.
    J Med Chem; 2006 Dec 28; 49(26):7854-60. PubMed ID: 17181168
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J, Yue J, Wu J, Luo R, Hu Z, Li J, Bai Y, Tang Z, Xian Q, Zhang X, Wang H.
    Pharmacology; 2010 Dec 28; 85(6):365-71. PubMed ID: 20530976
    [Abstract] [Full Text] [Related]

  • 10. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS, Raghunathan R, Ekambaram R, Raghunathan M.
    Int J Antimicrob Agents; 2009 Nov 28; 34(5):451-3. PubMed ID: 19625168
    [Abstract] [Full Text] [Related]

  • 11. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
    Xu ZQ, Barrow WW, Suling WJ, Westbrook L, Barrow E, Lin YM, Flavin MT.
    Bioorg Med Chem; 2004 Mar 01; 12(5):1199-207. PubMed ID: 14980631
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases.
    Camacho-Corona Mdel R, Ramírez-Cabrera MA, Santiago OG, Garza-González E, Palacios Ide P, Luna-Herrera J.
    Phytother Res; 2008 Jan 01; 22(1):82-5. PubMed ID: 17726732
    [Abstract] [Full Text] [Related]

  • 15. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
    Mehta A, Srivastva G, Kachhwaha S, Sharma M, Kothari SL.
    J Ethnopharmacol; 2013 Aug 26; 149(1):195-200. PubMed ID: 23816500
    [Abstract] [Full Text] [Related]

  • 16. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T, Fukuoka T, Doi N, Harasaki T, Inoue H, Hotoda H, Kakuta M, Muramatsu Y, Yamamura N, Hoshi M, Hirota T.
    J Antimicrob Chemother; 2004 Oct 26; 54(4):755-60. PubMed ID: 15347635
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
    Ermertcan S, Hosgor-Limoncu M, Erac B, Tasli H, Cavusoglu C, Bozkurt H.
    Jpn J Infect Dis; 2009 Sep 26; 62(5):384-5. PubMed ID: 19762990
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.